Cargando…
Momordicine-I, a Bitter Melon Bioactive Metabolite, Displays Anti-Tumor Activity in Head and Neck Cancer Involving c-Met and Downstream Signaling
SIMPLE SUMMARY: The incidence of head and neck cancer (HNC), one of the most aggressive cancers, is increasing rapidly globally. Conventional and targeted therapies show limited success with several undesirable side effects. Thus, there is a critical clinical need to identify additional alternative...
Autores principales: | Sur, Subhayan, Steele, Robert, Isbell, T. Scott, Venkata, Kalyan Nagulapalli, Rateb, Mostafa E., Ray, Ratna B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003975/ https://www.ncbi.nlm.nih.gov/pubmed/33801016 http://dx.doi.org/10.3390/cancers13061432 |
Ejemplares similares
-
Diverse roles of bitter melon (Momordica charantia) in prevention of oral cancer
por: Sur, Subhayan, et al.
Publicado: (2021) -
Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy
por: Sur, Subhayan, et al.
Publicado: (2020) -
Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
por: Sur, Subhayan, et al.
Publicado: (2019) -
Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death
por: Muhammad, Naoshad, et al.
Publicado: (2017) -
Correction to: Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract
por: Sur, Subhayan, et al.
Publicado: (2019)